WillItSurvive
Medical technology and health companies · United States

Clover Health

cloverhealth.com ↗

Medicare Advantage insurer running its own AI-assisted clinical software for physicians.

Losing its protection
Assessed 22 July 2026 · Evidence as of 22 July 2026
The structural protection is eroding.
On the recordSince 22 July 2026 · Checkable from August 5, 2026 · Every call on the record Checkpoint: Q2 2026 earnings release
The call

Clover just turned profitable and is growing fast, but its margins are thin and its tech model has no wall stopping bigger insurers from copying it.

Clover Health sells Medicare Advantage insurance plans (coverage for people over 65) and uses software called Counterpart Health to help doctors write better patient notes and make faster decisions. It is hard to copy because Clover needs a government license to sell insurance and has built up years of patient data, but UnitedHealthcare and Humana are massive competitors with their own data and artificial intelligence tools, and nothing stops them from copying Clover's doctor-friendly network model. The one thing that could matter: if Counterpart Health becomes a standalone software business that sells to many hospitals and clinics, it could become valuable on its own even if the insurance side struggles, but right now it is hidden inside Clover's overall numbers.

Why
01
AI pressure: Generic frontier AI models (Claude, GPT) deployed by rivals into clinical documentation tools. If UnitedHealth or Humana wire similar AI into their own doctor networks, Clover's data edge shrinks fast. Could AI do the core job? Only partly.
02
Bigger players: UnitedHealthcare (Optum) and Humana. Both already run large MA plans with their own clinical-data and AI systems; nothing stops them copying Clover's PPO model. Could a giant copy it? Yes, easily.
03
What protects it. CMS licensing plus physician-embedded Counterpart Health software and 95%+ member retention make Clover hard to swap out quickly.
What would change this call
Clover Health Q2 2026 earnings release on August 5, 2026. shows whether Q1 profitability and 51% membership growth held or reversed.
CMS 2027 Star Ratings recalculation after sector litigation including Elevance's July 2026 suit. shows whether Clover's bonus payments hold on merit or get clawed back.
Whether Clover breaks out Counterpart Health as a separate SaaS revenue line. shows whether it is becoming a data-platform business or stays a thin-margin insurer.
Key numbers
  • Q1 2026 revenue $749M, up 62% YoY (2026-03-31)
  • Q1 2026 net income $27.3M, first profitable quarter (2026-03-31)
  • MA membership 155,773, up 51% YoY (2026-03-31)
Named risks
  • Data breach disclosed July 17, 2026 involving employee accounts with member PII/PHI, class-action already filed. Severity: high
  • FY2026 net income guidance of only $0-20 million on $2.9B revenue leaves no margin cushion. Severity: high
  • CMS Star Ratings litigation and policy flux, with Elevance's July 1, 2026 suit signaling ongoing regulatory turbulence. Severity: medium
  • Interim CFO Clay Thornton in place since March 30, 2026 pending permanent replacement. Severity: medium
  • CEO Andrew Toy sold ~$1.67 million in shares on July 1, 2026 amid other insider sales in June 2026. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
UnitedHealthcarecontesting7.64M members, 25.8% share, but share slipped from 27.8% amid ~725K member loss in 2026
Humanagaining onAdded ~1.03M members (+20% YoY), share rose to 21.1%, 887 plans as of mid 2026
Oscar Healthgaining onExited standalone Medicare Advantage in 2025 to refocus on ACA and employer plans
Bright Healthgaining onExited the Medicare Advantage market per industry commentary, cited March 2026
Devoted HealthcontestingPrivately held payvidor model reportedly valued at $12.9B after $175M Series E
Questions people ask
Is Clover Health profitable in 2026?
Clover Health posted its first sustained GAAP-profitable quarter in Q1 2026 with $27.3 million net income on $749 million revenue, versus a $1.3 million loss a year earlier. FY2026 guidance calls for only $0-20 million net income on $2.81-2.92 billion revenue, so margins remain razor thin.
Who is Clover Health's biggest competitor?
UnitedHealthcare (about 7.64 million Medicare Advantage members, 25.8% share) and Humana (21.1% share after adding roughly 1.03 million members in 2025-2026) dominate the market. KFF found one of these two insurers is dominant in two-thirds of U.S. counties as of August 2025.
Could AI replace Clover Health?
AI cannot replace Clover's CMS-licensed, risk-bearing insurer status, but its Counterpart Health SaaS clinical-documentation layer, which launched a generative AI chat feature in fall 2025, could be commoditized if incumbents like Optum or CenterWell deploy comparable tools at scale.
Is Clover Health a safe company to join?
Headcount estimates range from about 602 (Revelio Labs, Dec 2025) to 724 (Macrotrends, Dec 2025) with job postings up 45.9% YoY in 2025, signaling rehiring. However, CFO Peter Kuipers departed March 30, 2026, and CEO Andrew Toy sold about $1.67 million in shares on July 1, 2026.
Did Clover Health have a data breach?
Yes. Clover filed an 8-K on July 17, 2026 disclosing a cybersecurity incident discovered July 4, 2026, in which a threat actor used social engineering to access three employee accounts containing PII/PHI. A class-action investigation was underway as of July 20, 2026.
How fast is Clover Health growing?
Clover's Medicare Advantage membership hit 155,773 in Q1 2026, up 51% year over year, with retention exceeding 95% during the recent Annual Election Period, per the company's May 6, 2026 earnings report.
Timeline
  • 2026-07-178-K filed disclosing data breach discovered July 4, 2026 via social engineering of employee accounts
  • 2026-07-01CEO Andrew Toy sold about 313,476 shares (~$1.67M)
  • 2026-07-01Elevance Health sued CMS over $115M Star Ratings dispute
  • 2026-06-17CMS announced voluntary recalculation of 2027 Quality Bonus Payment ratings
  • 2026-05-27Court ruled CMS misused 20 measures; Clover's PPO Stars raised 3.5 to 4.5
  • 2026-05-06Q1 2026: revenue $749M (+62%), net income $27.3M, membership 155,773 (+51%)
  • 2026-03-30CFO Peter Kuipers departs; Clay Thornton named Interim CFO
  • 2026-02-26FY2025 results: revenue ~$1.92B, GAAP net loss ~$85.6M
  • 2025-10-14Counterpart Health expands HEDIS AI platform; Clover PPO ranked #1 nationally
  • 2021-01-08Clover goes public via SPAC merger on Nasdaq as CLOV
Revision history
22 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
NeuralinkKingmed DiagnosticsMeinian Onehealth
More in Medical technology and health companies →
Sources